37 related articles for article (PubMed ID: 29681496)
1. Corrigendum to "Small extracellular vesicles derived from human mesenchymal stem cells prevent Th17-dominant neutrophilic airway inflammation via immunoregulation on Th17 cells" [Int. Immunopharmacol. 133 (2024) 112126].
He BX; Fang SB; Xie YC; Lou DX; Wu ZC; Li CG; Liu XQ; Zhou ZR; Huang LX; Tian T; Chen DH; Fu QL
Int Immunopharmacol; 2024 Jun; 134():112339. PubMed ID: 38796405
[No Abstract] [Full Text] [Related]
2. Corrigendum to "Modulating endoplasmic reticulum stress attenuates mast cell degranulation" [Int. Immunopharmacol. 126 (2024) 111336].
Fan J; Ma L; Xie B; Qiu S; Song S; Tang Z; Wu Y; Huangfu H; Feng Y; Luo X; Yang P
Int Immunopharmacol; 2024 Jun; ():112497. PubMed ID: 38902129
[No Abstract] [Full Text] [Related]
3. Corrigendum to "Piperine inhibits proliferation of human osteosarcoma cells via G2/M phase arrest and metastasis by suppressing MMP-2/-9 expression" [Int. Immunopharmacol. 24(1) (2015) 50-58].
Zhang J; Zhu X; Li H; Li B; Sun L; Xie T; Zhu T; Zhou H; Ye Z
Int Immunopharmacol; 2024 Mar; 129():111493. PubMed ID: 38311512
[No Abstract] [Full Text] [Related]
4. Corrigendum to "Plasma levels of 12 different cytokines correlate to PD-1 inhibitor combined chemotherapy responses in advanced non-small-cell lung cancer patient" [Int. Immunopharmacol. 124(Part A) (2023) 110888].
Peng Y; Qi Q; Zhu M; Zhang Y; Bao Y; Liu Y
Int Immunopharmacol; 2023 Nov; 124(Pt A):110976. PubMed ID: 37778965
[No Abstract] [Full Text] [Related]
5. Corrigendum to "Different roles of bortezomib and ONX 0914 in acute kidney injury" [Int. Immunopharmacol. 82 (2020) 106259].
Zhang XZ; Han F; Ding CG; Dou M; Wang YX; Xue WJ; Ding XM; Zheng J; Xu CX; Tian PX
Int Immunopharmacol; 2024 Jan; 126():111189. PubMed ID: 38012900
[No Abstract] [Full Text] [Related]
6. Corrigendum to "Leukotriene D4 induces cellular senescence in osteoblasts" [Int. Immunopharmacol. 58 (2018)154-159].
Wei J; Chen S; Guo W; Feng B; Yang S; Huang C; Chu J
Int Immunopharmacol; 2024 Mar; 129():111673. PubMed ID: 38365537
[No Abstract] [Full Text] [Related]
7. Corrigendum to "Wedelolactone induces apoptosis and pyroptosis in retinoblastoma through promoting ROS generation" [Int. Immunopharmacol. 111 (2022) 108855].
Jiang H; Niu C; Guo Y; Liu Z; Jiang Y
Int Immunopharmacol; 2023 Dec; 125(Pt A):111146. PubMed ID: 37926666
[No Abstract] [Full Text] [Related]
8. Corrigendum to "The anaphylatoxin C5a: Structure, function, signaling, physiology, disease, and therapeutics" [Int. Immunopharmacol. 118 (2023) 110081].
Ghosh M; Rana S
Int Immunopharmacol; 2023 Dec; 125(Pt A):111089. PubMed ID: 37872057
[No Abstract] [Full Text] [Related]
9. Corrigendum to "Neuroprotective effect of Vesatolimod in an experimental autoimmune encephalomyelitis mice model" [Int. Immunopharmacol. 116 (2023) 109717].
Jiang X; Song Y; Fang J; Yang X; Mu S; Zhang J
Int Immunopharmacol; 2024 Feb; 128():111448. PubMed ID: 38191277
[No Abstract] [Full Text] [Related]
10. Corrigendum to "Evaluation of different types of adjuvants in a malaria transmission-blocking vaccine" [Int. Immunopharmacol. 131 (2024) 111817].
Yu X; Min H; Yao S; Yao G; Zhang D; Zhang B; Chen M; Liu F; Cui L; Zheng L; Cao Y
Int Immunopharmacol; 2024 Jun; ():112260. PubMed ID: 38926073
[No Abstract] [Full Text] [Related]
11. Corrigendum to "Neutrophil elastase in dexmedetomidine alleviating sepsis-related renal injury in rats" [Int. Immunopharmacol. 122 (2023) 110441].
Chen L; Li M; Lin Y; Li Y; Liang M; Zeng K
Int Immunopharmacol; 2024 Feb; 128():111577. PubMed ID: 38281885
[No Abstract] [Full Text] [Related]
12. Corrigendum to "What is the impact and efficacy of routine immunological, biochemical and hematological biomarkers as predictors of COVID-19 mortality?" [Int. Immunopharmacol. 105 (2022) 108542].
Huyut MT; Huyut Z; Ilkbahar F; Mertoğlu C
Int Immunopharmacol; 2023 Oct; 123():110821. PubMed ID: 37625945
[No Abstract] [Full Text] [Related]
13. Corrigendum to "The effectiveness of blood routine parameters and some biomarkers as a potential diagnostic tool in the diagnosis and prognosis of Covid-19 disease" [Int. Immunopharmacol. 98 (2021) 107838].
Huyut MT; İlkbahar F
Int Immunopharmacol; 2023 Oct; 123():110823. PubMed ID: 37661504
[No Abstract] [Full Text] [Related]
14. Corrigendum to "Curcumin attenuates sepsis-induced acute organ dysfunction by preventing inflammation and enhancing the suppressive function of Tregs" [Int. Immunopharmacol. 61 (2018) 1-7].
Chen L; Lu Y; Zhao L; Hu L; Qiu Q; Zhang Z; Li M; Hong G; Wu B; Zhao G; Lu Z
Int Immunopharmacol; 2024 Jun; ():112471. PubMed ID: 38879417
[No Abstract] [Full Text] [Related]
15. Corrigendum to "Photothermic therapy with cuttlefish ink-based nanoparticles in combination with anti-OX40 mAb achieve remission of triple-negative breast cancer" [Int. Immunopharmacol. 115 (2023) 109622].
Momenzadeh N; Hajian S; Shabankare A; Ghavimi R; Kabiri-Samani S; Kabiri H; Hesami-Zadeh K; Shabankareh ANT; Nazaraghay R; Nabipour I; Mohammadi M
Int Immunopharmacol; 2023 Nov; 124(Pt B):111035. PubMed ID: 37858486
[No Abstract] [Full Text] [Related]
16. Corrigendum to "Regulation of fetal hemoglobin expression during hematopoietic stem cell development and its importance in bone metabolism and osteoporosis" [Int. Immunopharmacol. 57 (2018) 112-120].
Kos O; Alexander C; Brandenburg K; Chen Z; Heini A; Heumann D; Khatri I; Mach JP; Rietschel ET; Terskikh A; Ulmer AJ; Waelli T; Yu K; Zähringer U; Gorczynski RM
Int Immunopharmacol; 2018 Jun; 59():413. PubMed ID: 29681496
[No Abstract] [Full Text] [Related]
17. Corrigendum to "An altered REDOX environment, assisted by over-expression of fetal hemoglobins, protects from inflammatory colitis and reduces inflammatory cytokine expression" [Int. Immunopharmacol. 50 (2017) 69-76].
Gorczynski RM; Alexander C; Brandenburg K; Chen Z; Heini A; Neumann D; Mach JP; Rietschel ET; Terskikh A; Ulmer AJ; Yu K; Zahringer U; Khatri I
Int Immunopharmacol; 2018 Jun; 59():414. PubMed ID: 29681495
[No Abstract] [Full Text] [Related]
18. Corrigendum to "Stereocalpin A inhibits the expression of adhesion molecules in activated vascular smooth muscle cells" [Int. Immunopharmacol. 12 (2012) 315-325].
Byeon HE; Park BK; Yim JH; Lee HK; Moon EY; Rhee DK; Pyo S
Int Immunopharmacol; 2019 Jan; 66():389. PubMed ID: 30503384
[No Abstract] [Full Text] [Related]
19. Corrigendum to "Sinomenine inhibits fibroblast-like synoviocyte proliferation by regulating α7nAChR expression via ERK/Egr-1 pathway" [Int. Immunopharmacol. 56 (2018) 65-70].
Yi L; Lyu YJ; Peng C; Zhu RL; Bai SS; Liu L; Wang PX; Zhou H; Dong Y
Int Immunopharmacol; 2018 Sep; 62():339. PubMed ID: 30007832
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
